Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remission
    Journal Article

    Iasonos, A.; Sabbatini, P.; Spriggs, D. R.; Aghajanian, C. A.; O'Cearbhaill, R. E.; Hensley, M. L.; Thaler, H. T.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma
    Journal Article

    Leitao, M. M. Jr; Hensley, M. L.; Barakat, R. R.; Aghajanian, C.; Gardner, G. J.; Jewell, E. L.; O'cearbhaill, R.; Soslow, R. A.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
    Meeting Abstract

    Aghajanian, C.; Finkler, N. J.; Rutherford, T.; Smith, D. A.; Yi, J.; Parmar, H.; Nycum, L. R.; Sovak, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Topoisomerase I inhibition in BRCA+ and BRCA- ovarian cancer (OC): A single-institution experience
    Meeting Abstract

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Bhatia, J.; Aghajanian, C.; Iasonos, A.; Spriggs, D. R.; Kauff, N. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431
    Meeting Abstract

    Hensley, M. L.; Kravetz, S. J.; Jia, X.; Tew, W. P.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C.; Zarwan, C.; Berlin, S. T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial carcinoma (EMC): A review of the MSKCC experience
    Meeting Abstract

    Grisham, R. N.; Adaniel, C. H.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical activity of the oral AKT inhibitor GSK2141795 (GSK795) in a phase I first-in-human study
    Meeting Abstract

    Burris, H. A.; Siu, L. L.; Infante, J. R.; Wheler, J. J.; Kurkjian, C.; Opalinska, J.; Smith, D. A.; Antal, J. M.; Gauvin, J. L.; Gonzalez, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Feasibility and yield of offering genetic counseling to all patients with newly diagnosed high-grade epithelial ovarian cancer
    Meeting Abstract

    Arnold, A. G.; Bhatia, J.; Phillips, M. F.; Gardner, G. J.; Bell-McGuinn, K. M.; Aghajanian, C.; Barakat, R. R.; Offit, K.; Kauff, N. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • First results from a phase I trial of AZD8055, a dual mTORC1 and mTORC2 inhibitor
    Meeting Abstract

    Banerji, U.; Aghajanian, C.; Raymond, E.; Kurzrock, R.; Blanco-Codesido, M.; Oelmann, E.; Grinsted, L.; Burke, W.; Kaye, S. B.; Naing, A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save